Eventide Asset Management - TALARIS THERAPEUTICS INC ownership

TALARIS THERAPEUTICS INC's ticker is TALS and the CUSIP is 87410C104. A total of 59 filers reported holding TALARIS THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
Eventide Asset Management ownership history of TALARIS THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$2,934,853
+84.3%
1,561,0920.0%0.05%
+74.2%
Q4 2022$1,592,314
-61.2%
1,561,0920.0%0.03%
-61.7%
Q3 2022$4,106,000
-41.7%
1,561,0920.0%0.08%
-46.4%
Q2 2022$7,041,000
-54.2%
1,561,0920.0%0.15%
-37.3%
Q1 2022$15,361,000
-35.6%
1,561,0920.0%0.24%
-21.0%
Q4 2021$23,869,000
+15.4%
1,561,0920.0%0.30%
+11.7%
Q3 2021$20,686,000
-7.7%
1,561,0920.0%0.27%
-9.3%
Q2 2021$22,411,0001,561,0920.30%
Other shareholders
TALARIS THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Qiming U.S. Ventures Management, LLC 2,932,606$8,240,62310.94%
BML Capital Management, LLC 2,000,000$5,620,0005.16%
Nantahala Capital Management 2,953,129$8,298,2920.71%
GREAT POINT PARTNERS LLC 1,000,000$2,810,0000.51%
Acuitas Investments, LLC 194,547$546,6770.32%
Affinity Asset Advisors, LLC 400,000$1,124,0000.32%
RA Capital Management 2,403,238$6,753,0990.13%
Artal Group S.A. 914,262$2,5690.11%
Blackstone Inc. 8,089,315$22,730,9750.10%
QVT Financial LP 589,314$1,655,9720.09%
View complete list of TALARIS THERAPEUTICS INC shareholders